Milos Opravil

10.8k total citations · 2 hit papers
145 papers, 7.2k citations indexed

About

Milos Opravil is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Milos Opravil has authored 145 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Infectious Diseases, 67 papers in Virology and 61 papers in Epidemiology. Recurrent topics in Milos Opravil's work include HIV/AIDS drug development and treatment (77 papers), HIV Research and Treatment (67 papers) and HIV/AIDS Research and Interventions (55 papers). Milos Opravil is often cited by papers focused on HIV/AIDS drug development and treatment (77 papers), HIV Research and Treatment (67 papers) and HIV/AIDS Research and Interventions (55 papers). Milos Opravil collaborates with scholars based in Switzerland, United States and United Kingdom. Milos Opravil's co-authors include Bernard Hirschel, Rainer Weber, Hansjakob Furrer, Pietro Vernazza, Bruno Ledergerber, Amalio Telenti, Enos Bernasconi, Rudolf Speich, Markus Flepp and Matthias Egger and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Milos Opravil

141 papers receiving 6.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1999 772 citations Bruno Ledergerber, Milos Opravil et al. profile →
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

2002 535 citations Laurent A. Décosterd, Hansjakob Furrer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Milos Opravil Switzerland	42	4.5k	3.6k	2.3k	1.2k	801	145	7.2k
Court Pedersen Denmark	48	3.6k 0.8×	2.8k 0.8×	3.4k 1.5×	2.3k 1.9×	282 0.4×	226	8.5k
David A. Cooper Australia	39	5.5k 1.2×	4.4k 1.2×	1.6k 0.7×	1.4k 1.2×	263 0.3×	118	7.1k
Gitte Kronborg Denmark	42	2.6k 0.6×	1.7k 0.5×	2.2k 0.9×	2.2k 1.8×	454 0.6×	168	6.5k
Patrick Yéni France	31	6.8k 1.5×	5.3k 1.5×	2.1k 0.9×	1.7k 1.4×	276 0.3×	89	8.5k
Esteban Ribera Spain	40	3.0k 0.7×	1.7k 0.5×	2.3k 1.0×	1.0k 0.9×	282 0.4×	231	5.5k
Jan Gerstoft Denmark	48	4.8k 1.1×	3.6k 1.0×	3.0k 1.3×	3.1k 2.6×	193 0.2×	303	9.2k
Keith Henry United States	49	4.4k 1.0×	3.9k 1.1×	1.9k 0.8×	1.4k 1.2×	127 0.2×	135	7.2k
Catherine Leport France	42	3.4k 0.8×	2.2k 0.6×	3.1k 1.3×	1.3k 1.1×	246 0.3×	121	6.5k
Jack Fuhrer United States	19	6.2k 1.4×	4.2k 1.2×	3.4k 1.5×	2.5k 2.1×	122 0.2×	33	9.3k
Shinichi Oka Japan	45	4.3k 1.0×	3.2k 0.9×	2.8k 1.2×	879 0.7×	170 0.2×	475	8.1k

Countries citing papers authored by Milos Opravil

Since Specialization

Citations

This map shows the geographic impact of Milos Opravil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milos Opravil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milos Opravil more than expected).

Fields of papers citing papers by Milos Opravil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milos Opravil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milos Opravil. The network helps show where Milos Opravil may publish in the future.

Co-authorship network of co-authors of Milos Opravil

This figure shows the co-authorship network connecting the top 25 collaborators of Milos Opravil. A scholar is included among the top collaborators of Milos Opravil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milos Opravil. Milos Opravil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Opravil, Milos, M. Rodríguez‐Torres, Jürgen K. Rockstroh, et al.. (2012). The Dose-Response Relationship of Peginterferon Alfa-2a and Ribavirin in the Treatment of Patients Coinfected with HIV-HCV. HIV Clinical Trials. 13(1). 33–45. 2 indexed citations

Cusini, Alexia, Pietro Vernazza, Sabine Yerly, et al.. (2012). Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(1). 28–35. 72 indexed citations

Nguyen, Alain, Alexandra Calmy, Véronique Schiffer, et al.. (2008). Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000–2006. HIV Medicine. 9(3). 142–150. 55 indexed citations

Pozniak, Anton, Milos Opravil, George Beatty, et al.. (2008). Effect of Baseline Viral Susceptibility on Response to Darunavir/Ritonavir versus Control Protease Inhibitors in Treatment-Experienced HIV Type 1-Infected Patients: POWER 1 and 2. AIDS Research and Human Retroviruses. 24(10). 1275–1280. 16 indexed citations

Opravil, Milos, et al.. (2008). Chronische Hepatitis B und C bei HIV-infizierten Patienten. DMW - Deutsche Medizinische Wochenschrift. 123(24). 753–769. 3 indexed citations

Opravil, Milos, et al.. (2008). Meningitis nach akuter Borrelia-burgdorferi-Infektion und HIV-Infektion. DMW - Deutsche Medizinische Wochenschrift. 122(39). 1178–1180. 5 indexed citations

Opravil, Milos, Matthias Cavassini, Enos Bernasconi, et al.. (2006). Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy. Clinical Microbiology and Infection. 12(7). 666–671. 11 indexed citations

Huttner, Benedikt & Milos Opravil. (2006). Die infektiöse Spondylitis. Zeitschrift für Rheumatologie. 65(1). 7–11. 4 indexed citations

Kaufmann, Gilbert R., H Furrer, Bruno Ledergerber, et al.. (2005). Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy. Clinical Infectious Diseases. 41(3). 361–372. 245 indexed citations

10.

Sitbon, Olivier, Virginie Gressin, Rudolf Speich, et al.. (2004). Bosentan for the Treatment of Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 170(11). 1212–1217. 180 indexed citations

11.

Opravil, Milos, et al.. (2004). Reply to Torre and Pugliese. Clinical Infectious Diseases. 39(10). 1550–1550. 1 indexed citations

12.

Taffé, Patrick, Martin Rickenbach, Bernard Hirschel, et al.. (2002). Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study. AIDS. 16(5). 747–755. 40 indexed citations

13.

Fischer, Marek, Huldrych F. Günthard, Milos Opravil, et al.. (2000). Residual HIV-RNA Levels Persist for Up to 2.5 Years in Peripheral Blood Mononuclear Cells of Patients on Potent Antiretroviral Therapy. AIDS Research and Human Retroviruses. 16(12). 1135–1140. 46 indexed citations

14.

Schüpbach, Jörg, Zuzana Tomasik, David Nadal, et al.. (2000). Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. International Journal of Antimicrobial Agents. 16(4). 441–445. 30 indexed citations

15.

Stürmer, Jörg, et al.. (1999). Bilateral cystoid macular edema following successful treatment of AIDS-associated CMV retinitis. Der Ophthalmologe. 96(2). 87–91. 1 indexed citations

16.

Rothen, Madeleine, Leslie R. Bisset, H. I. Joller‐Jemelka, et al.. (1998). Improvement in Immune Function due to Treatment with Indinavir despite Severe Immune Deficiency. Antiviral Therapy. 3(3). 159–167. 1 indexed citations

17.

Opravil, Milos, M. Péchère, Rudolf Speich, et al.. (1997). HIV-Associated Primary Pulmonary Hypertension. A Case Control Study. Swiss HIV Cohort Study. American Journal of Respiratory and Critical Care Medicine. 155(3). 990–995. 210 indexed citations

18.

Sudre, Philippe, Milos Opravil, Victor Gabriel, et al.. (1997). Cytomegalovirus Retinitis: Decreased Risk of Bilaterality with Increased Use of Systemic Treatment. Clinical Infectious Diseases. 24(4). 620–624. 4 indexed citations

19.

Bisset, Leslie R., Milos Opravil, Elisabeth Ludwig, & Walter Fierz. (1993). T Cell Response to Staphylococcal Superantigens by Asymptomatic HIV-infected Individuals Exhibits Selective Changes in T Cell Receptor V _β -Chain Usage. AIDS Research and Human Retroviruses. 9(3). 241–246. 9 indexed citations

20.

Opravil, Milos, Andrew Gorman, & Tom C. Krejcie. (1983). Pulmonary artery balloon counterpulsation for right ventricular failure. 34. 282–285. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact